Generali Asset Management’s Hologic HOLX Stock Holding History

Generali Asset Management’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-25,588	Closed	-$1.93M	–	534
2026 Q1	$1.93M	Buy	25,588 +601	+2%	+$45.2K	0.04%	301
2025 Q4	$1.86M	Buy	24,987 +1,211	+5%	+$88.5K	0.04%	314
2025 Q3	$1.6M	Buy	23,776 +741	+3%	+$49.2K	0.03%	346
2025 Q2	$1.5M	Sell	23,035 -39,367	-63%	-$2.36M	0.03%	367
2025 Q1	$3.85M	Buy	62,402 +6,362	+11%	+$422K	0.1%	206
2024 Q4	$4.04M	Buy	+56,040	New	+$4.38M	0.1%	191

Other funds holding HOLX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Generali Asset Management's HOLX Position: Q2 2026 in Review

Generali Asset Management sold out of Hologic (HOLX) in Q2 2026, closing a stake of 25,588 shares — an estimated $1.93M sold.

Generali Asset Management first reported a position in HOLX in Q4 2024 and held it in 6 quarters. The position peaked at $4.04M in Q4 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

Generali Asset Management reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
Generali Asset Management sold 25,588 Hologic shares in Q2 2026, an estimated $1.93M.
Generali Asset Management first reported a position in Hologic in Q4 2024 and held it in 6 quarters.
Generali Asset Management's Hologic position peaked at $4.04M in Q4 2024.
3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Generali Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.